Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Mogamulizumab Boosts Survival in Rare Skin Cancers
Biotech & Bioprocessing Mogamulizumab Boosts Survival in Rare Skin Cancers

In a landscape where rare diseases often struggle for attention and innovation, cutaneous T-cell lymphoma (CTCL)—encompassing mycosis fungoides (MF) and Sézary syndrome (SS)—stands as a stark reminder of unmet medical needs. With only a small fraction of cancer cases attributed to these conditions,

How Does Hydrogen Shape Gut Health Beyond Flatulence?
Research & Development How Does Hydrogen Shape Gut Health Beyond Flatulence?

Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, and a deep passion for innovation in the industry. Ivan has been at the forefront of groundbreaking studies on the gut microbiome, particularly focusing on the

Fitness Apps May Harm Mental Health, Study Finds
Tech & Innovation Fitness Apps May Harm Mental Health, Study Finds

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of knowledge in tech and innovation within the industry. With his extensive background in research and development, Ivan brings a unique perspective to the intersection of technology and health. Today, we're

Pioneering Cell-Free Biomanufacturing for a New Frontier
Biotech & Bioprocessing Pioneering Cell-Free Biomanufacturing for a New Frontier

Imagine a future where life-saving medications and sustainable agricultural chemicals can be produced without the unpredictability and inefficiencies tied to living cells, a vision that is rapidly becoming reality through the innovative field of cell-free biomanufacturing. This transformative

Is the U.S. Health Care System Truly a Free Market?
Management & Regulatory Is the U.S. Health Care System Truly a Free Market?

The U.S. health care system is often touted as a bastion of free-market principles, yet a closer examination reveals a landscape riddled with contradictions that challenge this notion and expose deep-rooted issues. With annual health care spending surpassing $4 trillion, the stakes are enormous,

Exelixis Stock Drops on Mixed Colorectal Cancer Trial Data
Research & Development Exelixis Stock Drops on Mixed Colorectal Cancer Trial Data

The biotechnology sector often rides a rollercoaster of high hopes and sharp setbacks, and few cases illustrate this better than the recent plunge in Exelixis’ stock value following the release of data from its STELLAR-303 trial. Focused on zanzalintinib, an experimental drug for metastatic

Why Is Johnson & Johnson Facing a $966M Talc Verdict?
Research & Development Why Is Johnson & Johnson Facing a $966M Talc Verdict?

In a stunning turn of events that has captured national attention, a Los Angeles jury recently ordered Johnson & Johnson, a multinational giant in the healthcare industry, to pay a staggering $966 million to the family of Mae Moore, a California resident who tragically passed away in 2021 from

Hidden Fat Linked to Artery Damage in Groundbreaking Study
Research & Development Hidden Fat Linked to Artery Damage in Groundbreaking Study

The startling reality that over 30% of adults may carry dangerous fat deposits deep within their abdomen or liver, even without visible signs of obesity, has sparked intense discussion in the medical community. This hidden fat, often undetectable through traditional measures like body mass index

Can Ozempic Interfere With Cancer Detection in Scans?
Tech & Innovation Can Ozempic Interfere With Cancer Detection in Scans?

In a startling revelation that has caught the attention of the medical community, a popular medication used for weight loss and diabetes management, Ozempic, may pose an unexpected challenge in the realm of diagnostic imaging. Known for its effectiveness in controlling blood sugar and aiding

Can Tecvayli Redefine Early Treatment for Multiple Myeloma?
Research & Development Can Tecvayli Redefine Early Treatment for Multiple Myeloma?

In the quiet corridors of cancer research, a seismic shift is stirring for those battling multiple myeloma, a blood cancer that relentlessly challenges both patients and clinicians, igniting hope for a breakthrough. Picture a patient, exhausted after rounds of treatment, hoping for a breakthrough

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later